Allied Biotech Corporation (TPEX:1780)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
24.80
+0.75 (3.12%)
Aug 19, 2026, 1:30 PM CST

Allied Biotech Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
180.52129.46100.9497.41146.7413.04
Depreciation & Amortization
61.136161.9469.4571.7665.24
Loss (Gain) From Sale of Assets
-0.060.86--1.59-
Provision & Write-off of Bad Debts
-0.42---2-
Other Operating Activities
19.624.16-2.7-16.6231.82-9.13
Change in Accounts Receivable
-44.3-6.7-21.698.62-16.213.7
Change in Inventory
11.6816.1373.94-5-88.39-22.84
Change in Accounts Payable
-1.573.9-1.4-10.69-0.4110.7
Change in Unearned Revenue
1.31-0.91-2.043.39-0.340.88
Change in Other Net Operating Assets
10.459.2514.8-8.9515.70.83
Operating Cash Flow
261.59217.13223.79137.62164.2772.43
Operating Cash Flow Growth
79.32%-2.98%62.62%-16.23%126.81%21.77%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-38.12-33.58-26.81-47.91-54.66-49.99
Sale of Property, Plant & Equipment
0.06---0.11-
Investment in Securities
-91.45-55.9297.376.98273.57-130.95
Other Investing Activities
-0.030.02-0.02-0.01--
Investing Cash Flow
-129.55-89.4970.55-40.94219.02-180.94

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--170--265
Long-Term Debt Issued
--58.87-107.68-
Total Debt Issued
-17-228.87-107.68265
Short-Term Debt Repaid
--200--20-390-
Long-Term Debt Repaid
--24.04-82.99-24.17-132.32-24.76
Total Debt Repaid
-224.01-224.04-82.99-44.17-522.32-24.76
Net Debt Issued (Repaid)
-241.01-224.04145.88-44.17-414.64240.24
Common Dividends Paid
-96.02-96.02-81.42-114.46-47.68-76.12
Other Financing Activities
0.590.730.480.30.320.12
Financing Cash Flow
-39.64-319.3364.94-158.33-462164.24

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
3.572.440.560.391.07-1.82
Net Cash Flow
95.97-189.25359.84-61.26-77.6453.91

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
223.47183.55196.9889.71109.6222.44
Free Cash Flow Growth
94.83%-6.82%119.58%-18.16%388.49%744.88%
Free Cash Flow Margin
24.22%21.61%24.41%12.45%15.29%3.32%
Free Cash Flow Per Share
2.301.902.040.941.140.23
Levered Free Cash Flow
157.87104.19135.0233.0417.5265.85
Unlevered Free Cash Flow
167.2115.02143.7441.1324.8672.88

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
14.9517.3313.5812.8711.6511.06
Cash Income Tax Paid
32.0930.7332.5540.655.6613.88
Change in Working Capital
-22.4321.6763.61-12.63-89.633.28